Renacon Pharma Ltd.

renaconpharma.com

RENACON PHARMA Limited is the pioneer producer of high-quality powder, solution and cartridge forms of Kidney Dialysis (Hemodialysis) Concentrates since 1997 in Pakistan with ISO 13485, ISO 9001, CE 0120 & GMP certifications through SGS (UK) while FDA (USA) approval is underway. Company has free-sale authorization for Europe as endorsed by MHRA,UK.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Business Insights

AMPLICORE, INC. ANNOUNCES US FDA CLEARANCE OF FIRST INVESTIGATIONAL NEW DRUG APPLICATION (IND) AND ADDITION OF EXPERIENCED FINANCIAL LEADER TO BOARD

Amplicore, Inc. | July 15, 2022

news image

Amplicore Inc., a Mason, OH-based, early-stage biopharmaceutical company specializing in the development of minimally invasive therapeutic solutions for musculoskeletal disorders, today announced that the Food and Drug Administration has cleared their first application for AM3101, a novel treatment to promote healing of acute meniscal tears. The move enables the initiation of a Department of Defense-sponsored phase 1/2b clinical study in concert with the University of Cincinnati. ...

Read More

Pharmacy Market

VERIX ACQUIRES START-UP.AI, FURTHER ENHANCING ITS CAPABILITIES TO LEVERAGE THE POWER OF AI TO ACCELERATE BRAND GROWTH FOR LIFE SCIENCE COMPANIES

PRNewswire | June 16, 2023

news image

Verix, the leading provider of Tovana, an AI driven commercial optimization platform for the pharmaceutical industry, announced that it has acquired start-up.ai, a team of AI specialists that helps businesses improve their processes using artificial intelligence and machine learning. The start-up.ai team will be fully integrated into Verix's AI lab, with Shahar Cohen, start-up.ai's co-founder and CEO, to serve as Verix's CTO. Pharmaceutical companies currently often ...

Read More

Pharmacy Market

EYENOVIA'S NOVEL OPTEJET® DISPENSER PUTS PEOPLE'S EYES FIRST

Eyenovia | September 06, 2022

news image

Eyenovia, Inc. an ophthalmic pharmaceutical technology company developing a pipeline of microdose array print therapeutics, brings human-centric design to ophthalmology with its novel Optejet® dispenser. Traditional eye drops normally overdose the patient's eye with medication and preservatives. Eyenovia's easy-to-use, novel Optejet® dispenser administers precisely 8µL of medication to the eye, effectively treating the patient's condition while creating a...

Read More

Pharma Tech

ZERION PHARMA AND HOVIONE EXTEND PARTNERSHIP TO COVER USE OF THE DISPERSOME® TECHNOLOGY PLATFORM IN NUTRACEUTICALS

Zerion Pharma and Hovione | August 24, 2022

news image

Hovione and Zerion Pharma announced an extension of their collaboration on Zerion's Dispersome® technology into the nutraceutical/dietary supplements field. Many dietary supplements suffer from low solubility. This results in poor bioavailability and consequently limits the physiological effect of the supplement. To overcome these limitations, the two companies will collaborate and apply the solubility enhancing Dispersome® technology for the development and commercialization of cert...

Read More
news image

Business Insights

AMPLICORE, INC. ANNOUNCES US FDA CLEARANCE OF FIRST INVESTIGATIONAL NEW DRUG APPLICATION (IND) AND ADDITION OF EXPERIENCED FINANCIAL LEADER TO BOARD

Amplicore, Inc. | July 15, 2022

Amplicore Inc., a Mason, OH-based, early-stage biopharmaceutical company specializing in the development of minimally invasive therapeutic solutions for musculoskeletal disorders, today announced that the Food and Drug Administration has cleared their first application for AM3101, a novel treatment to promote healing of acute meniscal tears. The move enables the initiation of a Department of Defense-sponsored phase 1/2b clinical study in concert with the University of Cincinnati. ...

Read More
news image

Pharmacy Market

VERIX ACQUIRES START-UP.AI, FURTHER ENHANCING ITS CAPABILITIES TO LEVERAGE THE POWER OF AI TO ACCELERATE BRAND GROWTH FOR LIFE SCIENCE COMPANIES

PRNewswire | June 16, 2023

Verix, the leading provider of Tovana, an AI driven commercial optimization platform for the pharmaceutical industry, announced that it has acquired start-up.ai, a team of AI specialists that helps businesses improve their processes using artificial intelligence and machine learning. The start-up.ai team will be fully integrated into Verix's AI lab, with Shahar Cohen, start-up.ai's co-founder and CEO, to serve as Verix's CTO. Pharmaceutical companies currently often ...

Read More
news image

Pharmacy Market

EYENOVIA'S NOVEL OPTEJET® DISPENSER PUTS PEOPLE'S EYES FIRST

Eyenovia | September 06, 2022

Eyenovia, Inc. an ophthalmic pharmaceutical technology company developing a pipeline of microdose array print therapeutics, brings human-centric design to ophthalmology with its novel Optejet® dispenser. Traditional eye drops normally overdose the patient's eye with medication and preservatives. Eyenovia's easy-to-use, novel Optejet® dispenser administers precisely 8µL of medication to the eye, effectively treating the patient's condition while creating a...

Read More
news image

Pharma Tech

ZERION PHARMA AND HOVIONE EXTEND PARTNERSHIP TO COVER USE OF THE DISPERSOME® TECHNOLOGY PLATFORM IN NUTRACEUTICALS

Zerion Pharma and Hovione | August 24, 2022

Hovione and Zerion Pharma announced an extension of their collaboration on Zerion's Dispersome® technology into the nutraceutical/dietary supplements field. Many dietary supplements suffer from low solubility. This results in poor bioavailability and consequently limits the physiological effect of the supplement. To overcome these limitations, the two companies will collaborate and apply the solubility enhancing Dispersome® technology for the development and commercialization of cert...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us